prospectus
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Admissions T: +44 (0)1227 827272 www.kent.ac.uk/pg<br />
53<br />
for Biotechnologists and<br />
Bioengineers; Cancer Research<br />
in Focus; Cancer Therapeutics:<br />
From the Laboratory to the Clinic<br />
Infectious Diseases MSc<br />
www.kent.ac.uk/pg/361<br />
Location: Canterbury<br />
This MSc programme is for<br />
students who wish to gain an<br />
advanced education and training<br />
in the biological sciences within<br />
the context of a range of human<br />
diseases that affect a significant<br />
proportion of the global<br />
population.<br />
The programme provides training<br />
in the practical, academic and<br />
research skills that are used<br />
in academia and industry. It<br />
culminates with a research project<br />
under the supervision of expert<br />
staff who are currently conducting<br />
research on disease-causing<br />
microorganisms.<br />
Course content<br />
• Advances in Parasitology<br />
• Bacterial Pathogens<br />
• Fungi as Human Pathogens<br />
• Practical and Applied Research<br />
Skills for Advanced Biologists<br />
• Science @ Work<br />
• Viral Pathogens<br />
• Project/Dissertation<br />
Reproductive Medicine:<br />
Science and Ethics MSc<br />
www.kent.ac.uk/pg/228<br />
Location: Canterbury<br />
This programme is for those<br />
who wish to gain an advanced<br />
education and training within the<br />
context of a medical issue that<br />
affects one in six couples wishing<br />
to start a family.<br />
The MSc is taught by worldleading<br />
academics at the<br />
University of Kent and leading<br />
industry practitioners from<br />
The Bridge Centre, London.<br />
This programme provides you<br />
with a deep and broad overview<br />
of the modern practice of<br />
reproductive medicine.<br />
This programme is of interest to<br />
prospective researchers, clinical<br />
embryologists, clinical scientists<br />
or individuals simply interested<br />
in reproductive medicine.<br />
Course content<br />
• The IVF World<br />
• Practical and Applied Research<br />
Skills for Advanced Biologists<br />
• Reproduction and the<br />
Beginnings of Life<br />
• Science @ Work<br />
• The Science of Reproductive<br />
Medicine<br />
• Project/Dissertation<br />
Related taught programme<br />
Science, Communication and<br />
Society MSc<br />
See p214.<br />
Research programmes<br />
For the most up-to-date information,<br />
see website details below.<br />
Biochemistry MSc, MPhil,<br />
PhD<br />
www.kent.ac.uk/pg/229<br />
Cell Biology MSc, MPhil, PhD<br />
www.kent.ac.uk/pg/285<br />
Computational Biology MSc,<br />
MPhil, PhD<br />
www.kent.ac.uk/pg/1202<br />
Genetics MSc, MPhil, PhD<br />
www.kent.ac.uk/pg/286<br />
Microbiology MSc, MPhil, PhD<br />
www.kent.ac.uk/pg/287<br />
You can select topics for the MSc,<br />
MPhil or PhD from any of our<br />
research areas (see p54).<br />
We also offer a conventional<br />
MSc programme by research<br />
and dissertation, in which you<br />
undertake a single, focused,<br />
research project from day<br />
one, and attend only certain<br />
components of our transferable<br />
skills modules. We assign a<br />
STAFF PROFILE<br />
Michelle Garrett<br />
Professor of Cancer<br />
Therapeutics<br />
Michelle Garrett was appointed<br />
Chair of Cancer Therapeutics in<br />
September 2014.<br />
She studied at Leeds and The<br />
Institute of Cancer Research<br />
(ICR), London before moving<br />
to the US to undertake postdoctoral<br />
studies at Yale.<br />
Michelle worked for Onyx<br />
Pharmaceuticals in California,<br />
involved in the development of<br />
cancer drugs targeting the cell<br />
division cycle. Returning to the<br />
ICR in 1999, she became team<br />
leader in the Cancer Research<br />
UK Cancer Therapeutics Unit,<br />
with her research specialising in<br />
the discovery and development<br />
of novel small molecule<br />
therapeutics for the treatment of<br />
cancer. She became a Reader in<br />
Cancer Therapeutics and Head<br />
of Biology for the Unit. Michelle<br />
currently has two cancer drugs<br />
in the clinic.